Accretion Nutraveda Ltd vs Sanofi Consumer Healthcare India Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 18, 2026

Key Highlights

The Latest Trading Price of Accretion Nutraveda Ltd is ₹ 260 as of 18 May 15:30 . The p/e ratio of Accretion Nutraveda Ltd changed from 0 to 0 over 5 quarters. This represents a CAGR of 0.0% The p/e ratio of Sanofi Consumer Healthcare India Ltd changed from 62.6 to 0 over 4 quarters. This represents a CAGR of -100.00% The market cap of Accretion Nutraveda Ltd changed from ₹ 0 crore to ₹ 0 crore over 5 quarters. This represents a CAGR of 0.0% The market cap of Sanofi Consumer Healthcare India Ltd changed from ₹ 11347 crore to ₹ 0 crore over 4 quarters. This represents a CAGR of -100.00% The revenue of Accretion Nutraveda Ltd for the Jun '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Sanofi Consumer Healthcare India Ltd for the Jun '26 is ₹ 234.8 crore as compare to the Dec '25 revenue of ₹ 255.6 crore. This represent the decline of -8.14% The ebitda of Accretion Nutraveda Ltd for the Jun '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Sanofi Consumer Healthcare India Ltd for the Jun '26 is ₹ 94.4 crore as compare to the Dec '25 ebitda of ₹ 94.4 crore. This represent the decline of 0% The net profit of Accretion Nutraveda Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The net profit of Sanofi Consumer Healthcare India Ltd changed from ₹ 62.7 crore to ₹ 67.8 crore over 7 quarters. This represents a CAGR of 4.57% The dividend payout of Accretion Nutraveda Ltd changed from 0 % to 0 % over 5 quarters. This represents a CAGR of 0.0% The dividend payout of Sanofi Consumer Healthcare India Ltd changed from 6.06 % to 0 % over 5 quarters. This represents a CAGR of -100.00% .

About Accretion Nutraveda Ltd

Accretion Nutraveda Limited was initially incorporated as a Private Limited Company on March 16, 2021 and has subsequently, converted the status into a Public Limited Company vide Certificate of Incorporation issued by the Registrar of Companies, Central Processing Centre w.e.f.
May 2, 2025. The Company, established at Ahmedabad, is a healthcare-focused Contract Development and Manufacturing Organization (CDMO), offering specialized services to a diverse range of clients across the various industries.
It specialize in ayurvedic and nutraceutical products including Tablets, Capsules, Oral Liquids, Oral Powders, External Preparation and Oils.
Apart from these, it offer a diverse range of dosage forms, leveraging both Classical Ayurvedic principles and modern nutraceutical science. The products include Tablets, such as film-coated and chewable varieties, for applications in liver care, gynecological care, bone and joint health, and respiratory support.

About Sanofi Consumer Healthcare India Ltd

Sanofi Consumer Healthcare India Limited was incorporated on May 10, 2023, as part of Sanofi's global strategy to establish a standalone Consumer Healthcare business.
This strategic move resulted in the demerger of the Consumer Healthcare business from Sanofi India Limited (SIL) into the Company through a Scheme of Arrangement, thereby creating a distinct legal entity.
The Scheme of Arrangement, which was sanctioned by the National Company Law Tribunal, Mumbai (NCLT) enabled the seamless transfer and vesting of all assets, liabilities, and operations of SIL to the Company. Pursuant to the Scheme becoming effective, the Consumer Healthcare Division (CHC) business of Sanofi India Limited (SIL) got demerged into the Company as a going concern through the Scheme of Arrangement and became effective from June 1, 2024.

FAQs for the comparison of Accretion Nutraveda Ltd and Sanofi Consumer Healthcare India Ltd

Which company has a larger market capitalization, Accretion Nutraveda Ltd or Sanofi Consumer Healthcare India Ltd?

Market cap of Accretion Nutraveda Ltd is 196 Cr while Market cap of Sanofi Consumer Healthcare India Ltd is 11,180 Cr

What are the key factors driving the stock performance of Accretion Nutraveda Ltd and Sanofi Consumer Healthcare India Ltd?

The stock performance of Accretion Nutraveda Ltd and Sanofi Consumer Healthcare India Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Accretion Nutraveda Ltd and Sanofi Consumer Healthcare India Ltd?

As of May 18, 2026, the Accretion Nutraveda Ltd stock price is INR ₹272.0. On the other hand, Sanofi Consumer Healthcare India Ltd stock price is INR ₹4854.5.

How do dividend payouts of Accretion Nutraveda Ltd and Sanofi Consumer Healthcare India Ltd compare?

To compare the dividend payouts of Accretion Nutraveda Ltd and Sanofi Consumer Healthcare India Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.